‹ Go back to overview

Development of a revolving drug fund Nyamira / Nyanza Province

Field of Expertise:
Medical Products/ TechnologiesPolicy/strategy/DRA; PSCM /Financing and cost/pricingDrug Regulatory Authority; Essential Medicines Financing; Procurement / Tender / Quantification
Narrative description of project:
The Revolving Drug Fund project in Western Kenya was identified in 1994 by the Kenya – Belgium Joint Commission. A preliminary investigation consultancy (1997), presented a modified RDF pilot project proposal targeting all in and out patients in all public health facilities of Nyamira District in Nyanza Province, Western Kenya.
Description of services provided:

  • Identify critical indicators that should be monitored by the project to ensure that the project meets its objectives and becomes sustainable.

  • Discussion and advise on the identification of training needs, including training of trainers, in the draft set up and contents of the training programme and in the draft set up of training materials and training manuals.

  • Discussion and advise on the preparation of the required information materials for the public as part of the prevailing Information, Education and Communication.

  • Provide suggestions for defining the intervals for intermediate, internal self-evaluation.

  • Provide suggestions for joint GoK/MoH – BTC programme evaluations.

  • Overview the assessment of the existing policies on pricing and price setting, cost awareness and the existing exemption methods with the health staff and the public and discuss and give advice for the development of pricing methodology, price setting guidelines, exemption methodology and guidelines.

  • Overview of the assessment of existing situation with regard to drug management skills, operations, capacity and capabilities and give advice for adaptation to RDF requirements.

  • Discussion on guidelines in the development of RDF programme control and checking methods on administrative skills, quality of records and management of stocks and funds.

  • Discussion on guidelines in outlining the drafts for the procedure manual on the flow of drugs, storage and distribution within the system.